Company Filing History:
Years Active: 2018
Title: Victor Albert Eng: Pioneering Advances in Anti-CD47 Research
Introduction: Victor Albert Eng is an innovative inventor based in San Francisco, California. He has made significant contributions to the field of medical research, particularly in the realm of immunotherapy. His work has led to advancements that can potentially reshape treatment approaches for various diseases.
Latest Patents: Eng holds a patent titled "Methods for determining responsiveness to an anti-CD47 agent." This groundbreaking patent outlines methods and kits designed to assess an individual's responsiveness to anti-CD47 agents by analyzing biological samples for the levels or ratios of isoforms of CD47 present. This invention holds promise for enhancing personalized medicine strategies.
Career Highlights: Victor Eng is associated with Leland Stanford Junior University, where he applies his expertise in biomedicine. His research has played a critical role in understanding how anti-CD47 agents can be effectively utilized in therapeutic settings, especially in oncology.
Collaborations: Throughout his career, Eng has worked alongside esteemed colleagues, including Irving L. Weissman and Rahul Sinha. These collaborations have driven research efforts focused on cancer therapies and have significantly advanced the understanding of CD47's role in the immune response.
Conclusion: Victor Albert Eng stands out as a dedicated inventor whose work is pivotal in the field of medical research. His patent and ongoing contributions continue to inspire innovations that may greatly benefit patients and the medical community at large.